Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Zinc and prostatic cancer.

Ho E, Song Y.

Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):640-5. doi: 10.1097/MCO.0b013e32833106ee. Review.

2.

Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappaB and reduces the malignant potential of prostate cancer cells in vitro and in vivo.

Golovine K, Makhov P, Uzzo RG, Shaw T, Kunkle D, Kolenko VM.

Clin Cancer Res. 2008 Sep 1;14(17):5376-84. doi: 10.1158/1078-0432.CCR-08-0455.

3.
4.
5.

The involvement of Bax in zinc-induced mitochondrial apoptogenesis in malignant prostate cells.

Feng P, Li T, Guan Z, Franklin RB, Costello LC.

Mol Cancer. 2008 Mar 10;7:25. doi: 10.1186/1476-4598-7-25.

6.

Zinc transporters in prostate cancer.

Franz MC, Anderle P, Bürzle M, Suzuki Y, Freeman MR, Hediger MA, Kovacs G.

Mol Aspects Med. 2013 Apr-Jun;34(2-3):735-41. doi: 10.1016/j.mam.2012.11.007. Review.

7.

Zinc as an anti-tumor agent in prostate cancer and in other cancers.

Franklin RB, Costello LC.

Arch Biochem Biophys. 2007 Jul 15;463(2):211-7. Epub 2007 Mar 16. Review.

8.

Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands.

Johnson LA, Kanak MA, Kajdacsy-Balla A, Pestaner JP, Bagasra O.

Methods. 2010 Dec;52(4):316-21. doi: 10.1016/j.ymeth.2010.08.004. Epub 2010 Aug 10.

PMID:
20705137
9.

Zinc and zinc transporters in normal prostate and the pathogenesis of prostate cancer.

Franklin RB, Milon B, Feng P, Costello LC.

Front Biosci. 2005 Sep 1;10:2230-9. Review.

10.

Zinc induces mitochondria apoptogenesis in prostate cells.

Feng P, Liang JY, Li TL, Guan ZX, Zou J, Franklin R, Costello LC.

Mol Urol. 2000 Spring;4(1):31-6.

PMID:
10851304
11.

A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer.

Costello LC, Franklin RB.

Arch Biochem Biophys. 2016 Dec 1;611:100-112. doi: 10.1016/j.abb.2016.04.014. Epub 2016 Apr 27. Review.

12.

Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells.

Yan M, Song Y, Wong CP, Hardin K, Ho E.

J Nutr. 2008 Apr;138(4):667-73.

13.

Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.

Wei H, Desouki MM, Lin S, Xiao D, Franklin RB, Feng P.

Mol Cancer. 2008 Jan 21;7:7. doi: 10.1186/1476-4598-7-7.

14.

Genistein inhibits NF-kappa B activation in prostate cancer cells.

Davis JN, Kucuk O, Sarkar FH.

Nutr Cancer. 1999;35(2):167-74.

PMID:
10693171
15.
16.

Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway.

Golovine K, Uzzo RG, Makhov P, Crispen PL, Kunkle D, Kolenko VM.

Prostate. 2008 Sep 15;68(13):1443-9. doi: 10.1002/pros.20810.

17.

KRAS NF-κB is involved in the development of zinc resistance and reduced curability in prostate cancer.

Holubova M, Axmanova M, Gumulec J, Raudenska M, Sztalmachova M, Babula P, Adam V, Kizek R, Masarik M.

Metallomics. 2014 Jul;6(7):1240-53. doi: 10.1039/c4mt00065j.

PMID:
24927480
18.

Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States).

Costello LC, Franklin RB, Feng P, Tan M, Bagasra O.

Cancer Causes Control. 2005 Oct;16(8):901-15. Review.

PMID:
16132800
19.

hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer.

Franklin RB, Feng P, Milon B, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O, Costello LC.

Mol Cancer. 2005 Sep 9;4:32.

20.

Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.

Uzzo RG, Crispen PL, Golovine K, Makhov P, Horwitz EM, Kolenko VM.

Carcinogenesis. 2006 Oct;27(10):1980-90. Epub 2006 Apr 10.

PMID:
16606632

Supplemental Content

Support Center